Market Value: Pacira Corp (PCRX)

Official company branding of Pacira Corp (PCRX)

Extended-release postoperative pain management solutions have been integrated into hospital protocols, creating a sustainable cash flow driven by patents. The production of non-narcotic analgesics is localized in the US, ensuring stable demand. This price chart reflects a market capitalization of 1.46. Currently, Pacira BioSciences (PCRX) is normalizing its finances, leveraging the demand for non-opioid medications in elective procedures.

PCRX (Pacira BioSciences, Inc.) Market Capitalization history from 07/04/2022 to 11/11/2026

Comprehensive metric breakdowns and analytics for Pacira Corp (PCRX)

- current price and projected stock value:
Stock Price Pacira BioSciences, Inc.|PCRX - Consensus Target
- company stock exchange capitalization indicators:
Market Value Pacira Corp|PCRX - Value Adjusted for Debt and Cash
- book value of equity indicators:
Accounting Value per Share Pacira BioSciences|PCRX - Accounting Capitalization|Market Value to Book Value Ratio pacira.com|PCRX - Total Asset Value of Company
- debt and solvency information:
Total Debt to Capital Pacira BioSciences|PCRX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Pacira BioSciences|PCRX - Company Aggregate Debts|Debt to Book Capitalization Ratio Pacira Corp|PCRX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Pacira BioSciences|Quick Ratio pacira.com
- net income and valuation multiples indicators:
PCRX - Net Profit|Future Profit Pacira BioSciences|PCRX - Company Value to Net Income|Future Price to Earnings Pacira|PCRX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Pacira Corp|PCRX - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Pacira BioSciences|PCRX - Earnings per share for the trailing year|Quarterly EPS earnings growth pacira.com|PCRX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Pacira BioSciences
Fundamental company analysis:PCRX (Pacira BioSciences, Inc.)
Product sample of Pacira Corp

Market capitalization is the product of the current share price and the total number of outstanding shares, providing a real-time assessment of the business value. The trend in the issuer's total market capitalization reveals the underlying instability of Pacira BioSciences (PCRX), while the localization of non-opioid drug production minimizes geopolitical risks, ensuring the stability of the company's fundamental value.

Key competitors

Market Capitalization HLN (Haleon)|KVUE - Market Valuation|VRNA - Market Value|Market Value MENS (Jyong Bio)|LGND (Ligand Pharmaceuticals) - Market Valuation|Market Capitalization AMRX|Market Value Perrigo|Alvotech S.A. - Market Valuation|Market Capitalization LQDA|GLPG (Galapagos Corp) - Market Value|Market Capitalization ANIP (ANI Pharmaceuticals)|Market Capitalization mannkindcorp.com MNKD|AMPH - Market Value|Market Value SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Market Value|Market Valuation Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Market Capitalization|Market Capitalization Tectonic|Market Valuation TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Market Value|Market Value Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Market Value|EXOZ: Market Valuation|Oramed Pharmaceuticals - Market Value|ENTX: Market Capitalization|MindWalk Holdings, Inc. - Market Value|ABVC (ABVC BioPharma Inc) - Market Capitalization|Market Value Cumberland Corp CPIX|Market Value Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Market Value|Market Value Telomir Pharmaceuticals, Inc. TELO|RANI (Rani Therapeutics Holdings) - Market Valuation|Synergy CHC Corporation - Market Capitalization|RLYB - Market Capitalization|LEXX: Market Capitalization|Market Valuation pulmatrix.com|PTHL (Pheton Holdings Limited) - Market Capitalization|Aptorum (APM) - Market Capitalization|Market Value Lyra Therapeutics, Inc (LYRA)|IBO (impactbiomedinc.com) - Market Value|Market Capitalization TNFA (TNF Pharmaceuticals, Inc.)|Market Capitalization cbdMD Inc. YCBD|PRFX: Market Valuation|Market Value CYTO (Altamira Therapeutics)|LIPO: Market Capitalization|OPTN (OptiNose Corp) - Market Value|PIRS (Pieris Pharmaceuticals) - Market Capitalization|procapsgroup.com (PROC) - Market Capitalization|Market Value Petros Pharmaceuticals, Inc. (PTPI)|QLI - Market Value|Market Value ACELYRIN, Inc. SLRN|Market Capitalization TFF Pharmaceuticals, Inc (TFFP)